Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL.
Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Griffin R, et al. Among authors: van dyke dl. Blood Adv. 2023 Jul 11;7(13):3169-3179. doi: 10.1182/bloodadvances.2022009040. Blood Adv. 2023. PMID: 36877634 Free PMC article.
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA, Kenderian SS, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Hampel PJ, et al. Among authors: van dyke dl. Blood Cancer J. 2022 Sep 1;12(9):124. doi: 10.1038/s41408-022-00721-6. Blood Cancer J. 2022. PMID: 36050317 Free PMC article.
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.
Gagnon MF, Berg HE, Meyer RG, Sukov WR, Van Dyke DL, Jenkins RB, Greipp PT, Thorland EC, Hoppman NL, Xu X, Baughn LB, Reichard KK, Ketterling RP, Peterson JF. Gagnon MF, et al. Among authors: van dyke dl. Genes Chromosomes Cancer. 2022 Oct;61(10):629-634. doi: 10.1002/gcc.23070. Epub 2022 Jun 10. Genes Chromosomes Cancer. 2022. PMID: 35639830
CLL update 2022: A continuing evolution in care.
Kay NE, Hampel PJ, Van Dyke DL, Parikh SA. Kay NE, et al. Among authors: van dyke dl. Blood Rev. 2022 Jul;54:100930. doi: 10.1016/j.blre.2022.100930. Epub 2022 Jan 26. Blood Rev. 2022. PMID: 35151528 Review.
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
Wang H, Tian S, Zhao Q, Blumenschein W, Yearley JH, Secreto CR, Sinha S, Call TG, Wang Y, Parikh SA, Kenderian SS, He R, Leis JF, Shi M, Van Dyke DL, Kay NE, Slager SL, Braggio E, Yan H, Ding W. Wang H, et al. Among authors: van dyke dl. Hematol Oncol. 2022 Apr;40(2):302-306. doi: 10.1002/hon.2950. Epub 2021 Dec 3. Hematol Oncol. 2022. PMID: 34806797 No abstract available.
Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
Koleilat A, McGarrah PW, Olteanu H, Van Dyke DL, Smadbeck JB, Johnson SH, Vasmatzis G, Hoppman NL, Xu X, Ketterling RP, Greipp PT, Baughn LB, Patnaik MS, Peterson JF. Koleilat A, et al. Among authors: van dyke dl. Cancer Genet. 2022 Jan;260-261:1-5. doi: 10.1016/j.cancergen.2021.11.002. Epub 2021 Nov 6. Cancer Genet. 2022. PMID: 34781094
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Wang Y, Sinha S, Wellik LE, Secreto CR, Rech KL, Call TG, Parikh SA, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Van Dyke DL, Leis JF, Slager SL, Dong H, Kay NE, He R, Ding W. Wang Y, et al. Among authors: van dyke dl. Blood Cancer J. 2021 May 10;11(5):86. doi: 10.1038/s41408-021-00477-5. Blood Cancer J. 2021. PMID: 33972504 Free PMC article.
The prognostic significance of del6q23 in chronic lymphocytic leukemia.
Audil HY, Hampel PJ, Van Dyke DL, Achenbach SJ, Rabe KG, Smoley SA, Call TG, Ding W, Shi M, Hanson CA, Wang Y, Muchtar E, Koehler AB, Schwager SM, Leis JF, Braggio E, Slager SL, Kay NE, Kenderian SS, Parikh SA. Audil HY, et al. Among authors: van dyke dl. Am J Hematol. 2021 Jun 1;96(6):E203-E206. doi: 10.1002/ajh.26168. Epub 2021 Apr 7. Am J Hematol. 2021. PMID: 33749852 Free article. No abstract available.
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Hampel PJ, et al. Among authors: van dyke dl. Blood Cancer J. 2021 Mar 2;11(3):47. doi: 10.1038/s41408-021-00443-1. Blood Cancer J. 2021. PMID: 33654067 Free PMC article. No abstract available.
213 results